KRAS and cancer: One possible reason for this is that unlike our chemical screen, the previous chemical screens were not designed specifically to identify compounds that inhibit mutant  KRas-harboring/KRas-dependent, but not mt KRas-harboring/KRas-independent human cancer cell lines.